
ZERUN CO., LTD — Investor Relations & Filings
ZERUN CO., LTD. specializes in the research, development, and commercialization of innovative human vaccines. The organization utilizes advanced recombinant protein technology platforms to address significant public health challenges. Its primary product portfolio includes human papillomavirus (HPV) vaccines, specifically bivalent and nonavalent candidates designed to prevent cervical cancer. ZERUN CO., LTD. emphasizes the production of high-quality, affordable biological products to support global immunization efforts. The organization maintains rigorous quality control standards and operates large-scale manufacturing facilities to ensure the stable supply of preventive medicines. By leveraging its proprietary technical expertise, the company aims to improve health outcomes through the prevention of infectious diseases and virus-related malignancies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 申万宏源证券承销保荐有限责任公司关于江苏泽润新能科技股份有限公司2025年度跟踪报告 | 2026-05-22 | Chinese | |
| 广东信达律师事务所关于江苏泽润新能科技股份有限公司2025年年度股东会的法律意见书 | 2026-05-19 | Chinese | |
| 2025年年度股东会决议公告 | 2026-05-19 | Chinese | |
| 关于2023年股票期权激励计划第一个行权期集中行权结果暨股份上市的公告 | 2026-05-14 | Chinese | |
| 申万宏源证券承销保荐有限责任公司关于江苏泽润新能科技股份有限公司首次公开发行前已发行股份上市流通的核查意见 | 2026-05-13 | Chinese | |
| 关于首次公开发行前已发行股份上市流通提示性公告 | 2026-05-13 | Chinese |
Browse filings by year
2 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46784215 | 申万宏源证券承销保荐有限责任公司关于江苏泽润新能科技股份有限公司2025年度跟踪报告 | 2026-05-22 | Chinese | ||
| 46532359 | 广东信达律师事务所关于江苏泽润新能科技股份有限公司2025年年度股东会的法律意见书 | 2026-05-19 | Chinese | ||
| 46532385 | 2025年年度股东会决议公告 | 2026-05-19 | Chinese | ||
| 45959904 | 关于2023年股票期权激励计划第一个行权期集中行权结果暨股份上市的公告 | 2026-05-14 | Chinese | ||
| 45565085 | 申万宏源证券承销保荐有限责任公司关于江苏泽润新能科技股份有限公司首次公开发行前已发行股份上市流通的核查意见 | 2026-05-13 | Chinese | ||
| 45565648 | 关于首次公开发行前已发行股份上市流通提示性公告 | 2026-05-13 | Chinese | ||
| 44928445 | 广东信达律师事务所关于江苏泽润新能科技股份有限公司2023年股票期权激励计划调整行权价格的法律意见书 | 2026-05-11 | Chinese | ||
| 44928440 | 关于调整2023年股票期权激励计划行权价格及行权方式的公告 | 2026-05-11 | Chinese | ||
| 44928449 | 第二届董事会第三次会议决议公告 | 2026-05-11 | Chinese | ||
| 39596540 | 期货与衍生品交易管理制度 | 2026-04-28 | Chinese | ||
| 39596535 | 2025年度董事会工作报告 | 2026-04-28 | Chinese | ||
| 39596529 | 【2026-018】关于开展外汇衍生品交易及商品期货套期保值业务的公告 | 2026-04-28 | Chinese | ||
| 39596527 | 关于公司2026年度为子公司提供担保额度预计的公告 | 2026-04-28 | Chinese | ||
| 39596526 | 第二届董事会第二次会议决议公告 | 2026-04-28 | Chinese | ||
| 39596521 | 募集资金年度存放与使用情况鉴证报告 | 2026-04-28 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AFC-HD AMS Life Science Co.,Ltd.
An OEM of health foods, supplements, and cosmetics with int…
|
2927 | JP | Manufacturing |
|
Afexa Life Sciences Inc.
Researched, developed, and manufactured naturally derived O…
|
FXA | CA | Manufacturing |
|
AFT Pharmaceuticals Limited
Develops, licenses, and distributes pharmaceuticals across …
|
AFT | NZ | Manufacturing |
|
AFT PHARMACEUTICALS LIMITED
Develops and licenses healthcare products for pain manageme…
|
AFP | AU | Manufacturing |
|
AGENUS INC
A clinical-stage biotechnology company specializing in immu…
|
AGEN | US | Manufacturing |
|
AGIOS PHARMACEUTICALS, INC.
Biopharmaceutical company developing therapies for rare and…
|
AGIO | US | Manufacturing |
|
AGP Limited
Pharmaceutical company manufacturing, marketing, and distri…
|
AGP | PK | Manufacturing |
|
AHN-GOOK PHARMACEUTICAL Co., Ltd.
Develops and markets medicines, focusing on respiratory and…
|
001540 | KR | Manufacturing |
|
AIM Vaccine Co., Ltd.
Develops, manufactures, and commercializes established and …
|
6660 | HK | Manufacturing |
|
AION THERAPEUTIC INC.
Health and wellness company developing AI-driven bio-pharma…
|
AION | CA | Manufacturing |
ZERUN CO., LTD via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56405/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56405 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56405 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56405 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56405}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ZERUN CO., LTD (id: 56405)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.